These are news releases that are related to our Investor efforts.  Releases are listed in chronological order and are archived by year.  Sign-up to receive news as it is released using the email and RSS tools below.

Archives: Search / 2017 / 2016 / 2015 / 2014 / 2013 / 2012

2015 Archives

Dec 28, 2015
New technology will allow for the development of innovative drug candidates targeting immune checkpoints
Dec 14, 2015
Platform to be used to generate bi-specific antibodies against immuno-oncology targets
Dec 9, 2015
Additional Insider Buying Confirms Board and Management Confidence
Dec 7, 2015
New role strengthens Immune's ability to advance portfolio through strategic partnering
Nov 19, 2015
Appoints Miri Ben-Ami M.D. to EVP Oncology, President of Immune Ltd and Monica E. Luchi M.D. to EVP Global Drug Development, Chief Medical Officer
Nov 17, 2015
Phase 2 Clinical Trials Expanding to U.S. and Europe
Nov 12, 2015
Expansion of Bertilimumab Phase 2 Clinical Trials to the U.S. and Europe
Nov 9, 2015
Nov 5, 2015
Oct 15, 2015
Oct 7, 2015
Oct 1, 2015
Company Has Now Secured $16.5 Million Gross Proceeds out of the $21.5 Million July 2015 Financing
Sep 15, 2015
Two Board Members Recently Purchased 100,000 Shares
Sep 8, 2015
Sep 3, 2015
Aug 17, 2015
Aug 11, 2015
Jul 29, 2015
Up to $9.5 Million in Debt Financing and $12 Million in Equity Financing
Jul 17, 2015
Jul 13, 2015
Jul 8, 2015
Jun 29, 2015
Jun 25, 2015
2016 CLINICAL DEVELOPMENT PLANS TO BE PRESENTED AT IMMUNE R&D DAY ON SEPTEMBER 8, 2015
Jun 10, 2015
May 27, 2015
 

print email rss